Announcement  by unknown
76 ADACHI ET AL 
thus far obtained clearly indicate that t h e psoriatic lesional 
epidermis exists with the normal level of cyclic AMP. Further-
more, the data indicate that the cyclic AMP level in epidermis 
changes within seconds and minutes. In response to various 
stimuli , t h e levels change in a biphasic manner increasing 
rapidly and subsequently declining more slowly to normal levels 
[17-23]. In other words, the in vivo cyclic AMP level is dynamic 
rather t ha n static and thus a m easurement of the cyclic AMP 
level at a single t ime may not be of great value. Instead of the 
static measurement, more important information can probably 
be gained by testing the responses of epidermal adenylate 
cyclase to stimulation and by examining the following phospho-
rylation processes. As far as th e cyclic AMP system is con-
cerned, one biochemical abnormality repeatedly noted by us is 
the weakened response to ,8-adrenergic agonists by psoriatic 
epidermis [18,24]. This finding is not necessarily linked to the 
" low cyclic AMP level" in th e lesion but m ay be an indication 
of a membrane change in the complex process that is psoriasis. 
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Announcement 
A Dermatopathology Foundation Course in Gross and Microscopic Pathology of the Skin, will be held 
June 16 through 20, 1980 (Monday-Friday) at t he Sheraton-Deauville Hotel, Atlantic City, New Jersey. 
40 Hours Credit-A.M .A. Category 1. Write to: Dermatopathology Foundation P .O. Box 377 Canton 
MA 02021. . ' ' ' 
